Journal List > J Korean Neuropsychiatr Assoc > v.59(1) > 1143430

J Korean Neuropsychiatr Assoc. 2020 Feb;59(1):51-60. Korean.
Published online Feb 29, 2020.  https://doi.org/10.4306/jknpa.2020.59.1.51
Copyright © 2020 Korean Neuropsychiatric Association
Treatment Effect of Psychoeducation and Training Program Using Virtual Reality Technique in the Patients with Depressive Symptoms
MinJea Kim, MD,1,2 Sun-Woo Choi, MA,2 SunYoung Moon, MA,2 Hae-In Park, MA,2 HeeKyung Hwang, MA,2 Min-Kyeong Kim, MD, PhD,1,2 and Jeong-Ho Seok, PhD1,2
1Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea.
2Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Korea.

Address for correspondence: Jeong-Ho Seok, MD, PhD. Department of Psychiatry, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea. Tel +82-2-2019-3343, Fax +82-2-3462-4304, Email: johnstein@yuhs.ac
Received Sep 24, 2019; Revised Nov 14, 2019; Accepted Dec 09, 2019.

Abstract

Objectives

To compare the clinical effectiveness of the virtual reality (VR) programs in assessing psychosocial problems, improving symptoms, and reducing suicide risk in depressive patients with those of pharmacotherapy.

Methods

Thirty-six patients were recruited with depression in the treatment group and 22 participants in the healthy control group through internet advertisements between November 2018 and March 2019. Participants in the treatment group were allocated randomly at a 1:1 ratio to either the VR group or pharmacotherapy group. At the baseline, all participants were assessed with a comprehensive battery for their psychological characteristics by structured scales using VR technologies. Assessments of patients in the treatment group were repeated four weeks after therapeutic intervention. The primary outcome measures were the Korean Version of Quick Inventory of Depressive Symptomatology-Self-Report and suicidality scales of the Korean Mini International Neuropsychiatric interview. The borderline personality (Personality Assessment Inventory-Borderline Features Scale) and resilience (Korean Resilience Questionnaire) were also evaluated.

Results

Twenty-four depressive patients completed the treatment, and the final assessment was conducted after four weeks of treatment. In the initial assessment, the patient group showed significantly higher depressive symptoms, suicidality, borderline personality trait, and lower resilience than healthy control group. After the four-week therapeutic interventions, the VR group showed significant improvement in depression, suicidality, borderline personality trait, and resilience. In addition, there was no significant difference in the treatment efficacy between the VR group and the pharmacotherapy group.

Conclusion

In this study, the VR treatment program has clear benefits for emotional distress and reducing suicidality in depressive patients. Evidence-based VR treatments may show new clinical potential for depressive disorder.

Keywords: Virtual reality; Psychotherapy; Depressive disorder; Suicidal ideation

Figures


Fig. 1
A screenshot sample of the psychological characteristic evaluation test in virtual reality program.
Click for larger image


Fig. 2
A screenshot sample of an psycho-education session in virtual reality program.
Click for larger image


Fig. 3
A screenshot sample of a skill training session in virtual reality program.
Click for larger image

Tables


Table 1
The items of basic intellectual capacity screening test on reading comprehension and calculation for participation of virtual reality task
Click for larger image


Table 2
Overview of VR education/training program
Click for larger image


Table 3
Demographic data of the subjects
Click for larger image


Table 4
Comparison of baseline assessment among three groups
Click for larger image


Table 5
Changes in scores for psychological assessment of the VR and drug group
Click for larger image

Notes

Conflicts of Interest:The authors have no financial conflicts of interest.

Acknowledgments

This work was supported by the Technology Innovation Program (Research No. 10069086) funded by the Ministry of Trade, Industry & Energy (MOTIE, Republic of Korea).

References
1. World Health Organization. Preventing suicide: a global imperative. Luxembourg: World Health Organization; 2014.
2. Holma KM, Melartin TK, Haukka J, Holma IA, Sokero TP, et al. Incidence and predictors of suicide attempts in DSM-IV major depressive disorder: a five-year prospective study. Am J Psychiatry 2010;167:801–808.
3. OECD. Health at a glance 2015: OECD Indicators. Paris: OECD Publishing; 2015.
4. OECD. Health at a glance 2019: OECD Indicators. Paris: OECD Publishing; 2019.
5. kostat.go.kr [homepage on the Internet]. Statics of causes of death in Korea. Seoul: Korea National Statistical Office; 2017 [updated 2018 Sep 19]. [cited 2019 Jul 24].
6. Cuijpers P, van Straten A, van Oppen P, Andersson G. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry 2008;69:1675–1685.
7. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013;74:595–602.
8. Freeman D, Haselton P, Freeman J, Spanlang B, Kishore S, Albery E, et al. Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial. Lancet Psychiatry 2018;5:625–632.
9. Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B, et al. Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med 2017;47:2393–2400.
10. Shah LB, Torres S, Kannusamy P, Chng CM, He HG, Klainin-Yobas P. Efficacy of the virtual reality-based stress management program on stress-related variables in people with mood disorders: the feasibility study. Arch Psychiatr Nurs 2015;29:6–13.
11. Falconer CJ, Rovira A, King JA, Gilbert P, Antley A, Fearon P, et al. Embodying self-compassion within virtual reality and its effects on patients with depression. BJPsych Open 2016;2:74–80.
12. Bateman A, Fonagy P. Borderline personality disorder and mood disorders: mentalizing as a framework for integrated treatment. J Clin Psychol 2015;71:792–804.
13. Linehan MM, Wilks CR. The course and evolution of dialectical behavior therapy. Am J Psychother 2015;69:97–110.
14. Yoo SW, Kim YS, Noh JS, Oh KS, Kim CH, NamKoong K, et al. Validity of Korean Version of the Mini-International Neuropsychiatric Interview. Anxiety Mood 2006;2:50–55.
15. Yoon JH, Jon DI, Hong HJ, Hong N, Seok JH. Reliability and validity of the Korean Version of Inventory for Depressive Symptomatology. Mood Emot 2012;10:131–151.
16. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573–583.
17. Morey LC. In: Personality assessment inventory professional manual. Odessa, FL: Psychological Assessment Resources; 1991.
18. Hong SH, Kim YH. A validation study of the Borderline Personality Disorder Scale in Korean university students. Korean J Clin Psychol 1998;17:259–271.
19. Shin WY, Kim MG, Kim JH. Developing measures of resilience for Korean adolescents and testing cross, convergent, and discriminant validity. Stud Korean Youth 2009;20:105–131.
20. Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator ickness questionnaire: An enhanced method for quantifying simulator sickness. Int J Aviat Psychol 1993;3:203–220.
21. Bouchard S, Dumoulin S, Robillard G, Guitard T, Klinger É, Forget H, et al. Virtual reality compared with in vivo exposure in the treatment of social anxiety disorder: a three-arm randomised controlled trial. Br J Psychiatry 2017;210:276–283.
22. Bouchard S, St-Jacques J, Renaud P, Wiederhold B. Side effects of immersions in virtual reality for people suffering from anxiety disorders. J Cyber Ther Rehabil 2009;2:127–137.
23. Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry 2015;72:475–482.
24. Calati R, Courtet P. Is psychotherapy effective for reducing suicide attempt and non-suicidal self-injury rates? Meta-analysis and meta-regression of literature data. J Psychiatr Res 2016;79:8–20.
25. Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry 2017;74:319–328.